Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1
Zhenzhu Sun, Wenqiang Lu, Na Lin, et al.
Biochemical Pharmacology (2020) Vol. 175, pp. 113888-113888
Closed Access | Times Cited: 123

Showing 26-50 of 123 citing articles:

A hyaluronic acid/cyclodextrin based injectable hydrogel for local doxorubicin delivery to solid tumors
Calogero Fiorica, Fabio Salvatore Palumbo, Giovanna Pitarresi, et al.
International Journal of Pharmaceutics (2020) Vol. 589, pp. 119879-119879
Closed Access | Times Cited: 52
Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy
Xin Han, Chuan Hun Ding, Xianan Sang, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107983-107983
Closed Access | Times Cited: 49
Resveratrol reduces cardiac NLRP3‐inflammasome activation and systemic inflammation to lessen doxorubicin‐induced cardiotoxicity in juvenile mice
Zaid H. Maayah, Abrar S. Alam, Shingo Takahara, et al.
FEBS Letters (2021) Vol. 595, Iss. 12, pp. 1681-1695
Open Access | Times Cited: 43
SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy
Zhengzhu Sun, Chongfeng Fang, Shasha Xu, et al.
Biochemical Pharmacology (2022) Vol. 207, pp. 115354-115354
Closed Access | Times Cited: 31
Dihydromyricetin improves LPS-induced sickness and depressive-like behaviors in mice by inhibiting the TLR4/Akt/HIF1a/NLRP3 pathway
Yicong Wei, Yonghong Hu, Keming Qi, et al.
Behavioural Brain Research (2022) Vol. 423, pp. 113775-113775
Open Access | Times Cited: 30
Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
Yun Qiu, Piao Jiang, Yingmei Huang
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms
Xiaofeng Li
Environmental Research (2023) Vol. 234, pp. 116504-116504
Closed Access | Times Cited: 20
The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK
Tao Zhang, Lei Xu, Xiaowei Guo, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 2, pp. 157-176
Open Access | Times Cited: 19
Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin
Qiaohua Yan, Meiqing Li, Liying Dong, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125569-125569
Closed Access | Times Cited: 18
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Vincenzo Quagliariello, Maria Laura Canale, Isabella Bisceglia, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?
Cun Liu, Xiaoran Ma, Jing Zhuang, et al.
Pharmacological Research (2020) Vol. 160, pp. 105062-105062
Closed Access | Times Cited: 42
Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the ‎TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis
Asmaa I. Matouk, Eman M. Awad, Nashwa Fathy Gamal El‐Tahawy, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113752-113752
Open Access | Times Cited: 23
Cell death regulation in myocardial toxicity induced by antineoplastic drugs
Xue Yu, Yan Yang, Tianzuo Chen, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 16
Polyguluronic acid alleviates doxorubicin-induced cardiotoxicity by suppressing Peli1-NLRP3 inflammasome-mediated pyroptosis
Erlin Zhang, Chuangeng Shang, Mingtao Ma, et al.
Carbohydrate Polymers (2023) Vol. 321, pp. 121334-121334
Closed Access | Times Cited: 14
Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity
Xuan Zhang, Chaoming Huang, Yanhong Hou, et al.
Phytomedicine (2024) Vol. 129, pp. 155673-155673
Closed Access | Times Cited: 5
The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin
Zaid H. Maayah, Shingo Takahara, Jason R.B. Dyck
Archives of Toxicology (2020) Vol. 95, Iss. 1, pp. 1-9
Closed Access | Times Cited: 37
NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
Shanshan Wei, Wanjun Ma, Bikui Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 31
Date Palm Pollen Extract Avert Doxorubicin-Induced Cardiomyopathy Fibrosis and Associated Oxidative/Nitrosative Stress, Inflammatory Cascade, and Apoptosis-Targeting Bax/Bcl-2 and Caspase-3 Signaling Pathways
Samar S. Elblehi, Yasser El‐Sayed, Mohamed Mohamed Soliman, et al.
Animals (2021) Vol. 11, Iss. 3, pp. 886-886
Open Access | Times Cited: 29
A multifaceted review on dihydromyricetin resources, extraction, bioavailability, biotransformation, bioactivities, and food applications with future perspectives to maximize its value
Haolin Zhang, Giovanni Caprioli, Hidayat Hussain, et al.
eFood (2021) Vol. 2, Iss. 4, pp. 164-184
Open Access | Times Cited: 28
Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
Nonhlakanipho F. Sangweni, Derick van Vuuren, Lawrence Mabasa, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
Jiajun Wu, Zuowei Xiao, Hongfang Li, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3487-3487
Open Access | Times Cited: 22
Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
Ruirui Zhang, Hao Zhang, Houyin Shi, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3052-3070
Open Access | Times Cited: 22
A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency
Ruikun Lin, Lei Zhang, Biwei Ye, et al.
Cancer Letters (2023) Vol. 563, pp. 216181-216181
Closed Access | Times Cited: 11
A combination of isoliquiritigenin with Artemisia argyi and Ohwia caudata water extracts attenuates oxidative stress, inflammation, and apoptosis by modulating Nrf2/Ho‐1 signaling pathways in SD rats with doxorubicin‐induced acute cardiotoxicity
Dennis Jine Yuan Hsieh, Md. Nazmul Islam, Wei‐Wen Kuo, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 12, pp. 3026-3042
Open Access | Times Cited: 11
The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity
Xuening Liu, Zijian Li
Basic Research in Cardiology (2024)
Closed Access | Times Cited: 4

Scroll to top